{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T17:01:52Z","timestamp":1756573312075,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s12185-016-2131-y","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T09:03:57Z","timestamp":1478682237000},"page":"540-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia"],"prefix":"10.1007","volume":"105","author":[{"given":"Shojiro","family":"Haji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0403-0122","authenticated-orcid":false,"given":"Motoaki","family":"Shiratsuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamitsu","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-Ichi","family":"Imadome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"key":"2131_CR1","first-page":"276","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"JKC Chan","year":"2008","unstructured":"Chan JKC, Jaffe ES, Ralfkiaer E, Ko Y-H. Aggressive NK-cell leukaemia. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. 4th ed. Lyon: IARC Press; 2008. p. 276\u20137.","edition":"4"},{"key":"2131_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2141.1990.tb02615.x","volume":"75","author":"N Imamura","year":"1990","unstructured":"Imamura N, Kusunoki Y, Kawa-HaK Yumura K, Hara J, Oda K, et al. Aggressive natural killer cell leukaemia\/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol. 1990;75:49\u201359.","journal-title":"Br J Haematol"},{"key":"2131_CR3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1532\/IJH97.A10612","volume":"85","author":"J Ryder","year":"2007","unstructured":"Ryder J, Wang X, Bao L, Gross SA, Hua F, Irons RD. Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature. Int J Hematol. 2007;85:18\u201325.","journal-title":"Int J Hematol"},{"key":"2131_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1750-1172-8-95","volume":"8","author":"M Lima","year":"2013","unstructured":"Lima M. Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis. Orphanet J Rare Dis. 2013;8:95. doi: 10.1186\/1750-1172-8-95 .","journal-title":"Orphanet J Rare Dis."},{"key":"2131_CR5","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","volume":"27","author":"M Yamaguchi","year":"2009","unstructured":"Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, et al. Phase I\/II study of concurrent chemotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol. 2009;27:5594\u2013600.","journal-title":"J Clin Oncol"},{"key":"2131_CR6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.V93.2.599","volume":"93","author":"M Egashira","year":"1999","unstructured":"Egashira M, Kawamata N, Sugimoto K, Kaneko T, Oshimi K. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of p-glycoprotein function by cyclosporine A and its analogue, PSC833. Blood. 1999;93:599\u2013606.","journal-title":"Blood"},{"key":"2131_CR7","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hasegawa C, Suh C, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol. 2011;29:4410\u20136.","journal-title":"J Clin Oncol"},{"key":"2131_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13045-016-0271-4","volume":"6","author":"KS Jung","year":"2016","unstructured":"Jung KS, Cho SH, Kim SJ, Ko YH, Kang ES, Kim WS. l-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia. J Hematol Oncol. 2016;6:41.","journal-title":"J Hematol Oncol"},{"key":"2131_CR9","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(96)90325-6","volume":"347","author":"T Teshima","year":"1996","unstructured":"Teshima T, Miyaji R, Fukuda M, Ohshima K. Bone marrow transplantation for Epstein-Barr-virus-associated natural killer cell-large granular lymphocyte leukaemia. Lancet. 1996;347:1124.","journal-title":"Lancet"},{"key":"2131_CR10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0609.2008.01090.x","volume":"81","author":"T Ito","year":"2008","unstructured":"Ito T, Makishima H, Nakazawa H, Kobayashi H, Shimodaira S, Nakazawa Y, et al. Promissing approach for aggressive NK cell leukaemia with allogeneic haematopoietic cell transplantation. Eur J Haematol. 2008;81:107\u201311.","journal-title":"Eur J Haematol"},{"key":"2131_CR11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF02982726","volume":"76","author":"M Makita","year":"2002","unstructured":"Makita M, Maeda Y, Takenaka K, Shinagawa K, Sunami K, Hiramatsu Y, et al. Successful treatment of progressive NK cell lymphoma with allogeneic peripheral stem cell transplantation followed by early cyclosporine tapering and donor leukocyte infusions. Int J Hematol. 2002;76:94\u20137.","journal-title":"Int J Hematol"},{"key":"2131_CR12","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1200\/JCO.2007.14.1366","volume":"26","author":"S Gouill Le","year":"2008","unstructured":"Le Gouill S, Milpied N, Buzyn A, De Latour RP, Vernant JP, Mohty M, et al. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Mo\u00eblle et de Th\u00e9rapie Cellulaire. J Clin Oncol. 2008;26:2264\u201371.","journal-title":"J Clin Oncol"},{"key":"2131_CR13","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1182\/blood-2002-01-0039","volume":"100","author":"B Savoldo","year":"2002","unstructured":"Savoldo B, Huls MH, Liu Z, Okamura T, Volk HD, Reinke P, et al. Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood. 2002;100:4059\u201366.","journal-title":"Blood"},{"key":"2131_CR14","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","volume":"32","author":"CM Bollard","year":"2014","unstructured":"Bollard CM, Gottschalk S, Torrano V, Diouf O, Ku S, Hazrat Y, et al. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J Clin Oncol. 2014;32:798\u2013808.","journal-title":"J Clin Oncol"},{"key":"2131_CR15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15:486\u201399.","journal-title":"Nat Rev Immunol"},{"key":"2131_CR16","doi-asserted-by":"publisher","first-page":"e0136476","DOI":"10.1371\/journal.pone.0136476","volume":"10","author":"L Quan","year":"2015","unstructured":"Quan L, Chen X, Zhang Y, Guo X, Yan S, Liu Y. PD-1 blockade can restore functions of T-cells in Epstein-Barr virus-positive diffuse large B-cell lymphoma in vitro. PLoS ONE 2015;10:e0136476. doi: 10.1371\/journal.pone.0136476","journal-title":"PLoS ONE"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-2131-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-016-2131-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-2131-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T05:56:29Z","timestamp":1601186189000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-016-2131-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,9]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["2131"],"URL":"https:\/\/doi.org\/10.1007\/s12185-016-2131-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2016,11,9]]}}}